López, Manuel Rodríguez, and Michael Calviño Suarez. 2026. “Remission-Driven Discontinuation Shapes the Observed Duration of Emicizumab in Acquired Hemophilia A. Comment On: ‘Short-Term Emicizumab in Patients With Acquired Hemophilia A’”. Haematologica, August. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301818.